Giles G G, Marks R, Foley P
Anti-Cancer Council of Victoria, Carlton South, Australia.
Br Med J (Clin Res Ed). 1988 Jan 2;296(6614):13-7. doi: 10.1136/bmj.296.6614.13.
In 1985, as part of a national random household omnibus survey by a market research company, 30,976 Australians (mostly of European origin) were asked whether they had ever been treated by a doctor for skin cancer. The treating doctor or hospital was then approached for confirmation of the diagnosis of all those people who claimed to have been so treated within the past 12 months. Demographic data were also collected, permitting analysis by age, sex, country of birth, current residence, and skin reaction to strong sunlight. Melanomas accounted for less than 5% of the tumours treated. The world standardised incidence of melanoma was 19/100,000 population. The standardised incidence of treated non-melanocytic skin cancer in Australia was estimated to be 823/100,000. The standardised rates for basal cell carcinoma and squamous cell carcinoma were 657 and 166/100,000 respectively, yielding a standardised rate ratio of about 4:1. Standardised rates based on medically confirmed cases only were 555, 443, and 112/100,000 for all non-melanocytic skin cancers, basal cell carcinomas, and squamous cell carcinomas respectively. Significant differences and trends in incidence were noted with respect to age and sex. Rates in men were higher than those in women but significantly so only after the age of 60. People born in Australia had a rate of 936/100,000 compared with 402/100,000 in British migrants. Rates for non-melanocytic skin cancer showed a gradient with respect to latitude within Australia. The rate in people residing north of 29 degrees S was 1242/100,000 compared with a rate of 489/100,000 in those living south of 37 degrees S. A person's skin reaction to strong sunlight was a good indicator of the risk of skin cancer, tanning ability being inversely related to its incidence. The rate in those who always burnt and never tanned when exposed to strong sunlight was 1764/100,000 compared with a rate of 616/100,000 in those who always tanned and never burnt. These findings have important implications for public education programmes in relation to exposure to sunlight in Australia.
1985年,作为一家市场研究公司开展的全国随机家庭综合调查的一部分,30976名澳大利亚人(大多数为欧洲裔)被问及他们是否曾因皮肤癌接受过医生治疗。随后联系了治疗医生或医院,以确认所有声称在过去12个月内接受过此类治疗的人的诊断情况。还收集了人口统计学数据,以便按年龄、性别、出生国家、当前居住地以及对强光的皮肤反应进行分析。黑色素瘤占接受治疗的肿瘤的比例不到5%。黑色素瘤的世界标准化发病率为每10万人中有19例。澳大利亚经治疗的非黑素细胞性皮肤癌的标准化发病率估计为每10万人中有823例。基底细胞癌和鳞状细胞癌的标准化发病率分别为每10万人中有657例和166例,标准化发病率之比约为4:1。仅基于医学确诊病例的所有非黑素细胞性皮肤癌、基底细胞癌和鳞状细胞癌的标准化发病率分别为每10万人中有555例、443例和112例。在年龄和性别方面,发病率存在显著差异和趋势。男性的发病率高于女性,但仅在60岁以后差异显著。出生在澳大利亚的人的发病率为每10万人中有936例,而英国移民的发病率为每10万人中有402例。非黑素细胞性皮肤癌的发病率在澳大利亚境内随纬度呈现梯度变化。居住在南纬29度以北的人的发病率为每10万人中有1242例,而居住在南纬37度以南的人的发病率为每10万人中有489例。一个人对强光的皮肤反应是皮肤癌风险的良好指标,晒黑能力与其发病率呈负相关。在暴露于强光时总是晒伤且从不晒黑的人的发病率为每10万人中有1764例,而总是晒黑且从不晒伤的人的发病率为每10万人中有616例。这些发现对澳大利亚有关阳光暴露的公众教育计划具有重要意义。